These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 23282434)

  • 21. Cyclosporine augments renal but not systemic vascular reactivity.
    Garr MD; Paller MS
    Am J Physiol; 1990 Jan; 258(1 Pt 2):F211-7. PubMed ID: 2301592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sympathetic nerve activity in renal transplant patients before and after withdrawal of cyclosporine.
    Hausberg M; Lang D; Levers A; Suwelack B; Kisters K; Tokmak F; Barenbrock M; Kosch M
    J Hypertens; 2006 May; 24(5):957-64. PubMed ID: 16612259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cyclosporine bioavailability of two physically different oral formulations.
    Postolache P; Petrescu O; Dorneanu V; Zanini AC
    Eur Rev Med Pharmacol Sci; 2002; 6(6):127-31. PubMed ID: 12776806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of cyclosporine A dissolved in chremofore or in ethanol and of cortisone on the arterial release of prostacyclin.
    Brunkwall J; Bergqvist D
    J Surg Res; 1993 Dec; 55(6):622-7. PubMed ID: 8246495
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclosporine nephrotoxicity.
    Grinyó JM; Cruzado JM
    Transplant Proc; 2004 Mar; 36(2 Suppl):240S-242S. PubMed ID: 15041345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monitoring of cyclosporine 2-hour post-dose levels in heart transplantation: improvement in clinical outcomes.
    Delgado DH; Rao V; Hamel J; Miriuka S; Cusimano RJ; Ross HJ
    J Heart Lung Transplant; 2005 Sep; 24(9):1343-6. PubMed ID: 16143255
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of cyclosporine on anesthetic action.
    Cirella VN; Pantuck CB; Lee YJ; Pantuck EJ
    Anesth Analg; 1987 Aug; 66(8):703-6. PubMed ID: 3605689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Strong additive effect of 1,25-dihydroxycholecalciferol and cyclosporine A but not tacrolimus in rat lung allotransplantation.
    Stammberger U; Kubisa B; Gugger M; Ayuni E; Claudio R; Grodzki T; Schmid RA
    Eur J Cardiothorac Surg; 2003 Aug; 24(2):196-200; discussion 200. PubMed ID: 12895607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leflunomide in experimental transplantation. Control of rejection and alloantibody production, reversal of acute rejection, and interaction with cyclosporine.
    Williams JW; Xiao F; Foster P; Clardy C; McChesney L; Sankary H; Chong AS
    Transplantation; 1994 Apr; 57(8):1223-31. PubMed ID: 8178350
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclosporine and trends in kidney transplantation.
    Cicciarelli J
    Clin Transpl; 1986; ():223-30. PubMed ID: 3154406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclosporine A for induction of remission in severe ulcerative colitis.
    Shibolet O; Regushevskaya E; Brezis M; Soares-Weiser K
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004277. PubMed ID: 15674937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of calcineurin inhibitors on extracellular matrix turnover in isolated human glomeruli.
    Esposito C; Foschi A; Parrilla B; Cornacchia F; Fasoli G; Plati AR; De Mauri A; Mazzullo T; Scudellaro R; Dal Canton A
    Transplant Proc; 2004 Apr; 36(3):695-7. PubMed ID: 15110634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of cyclosporine A on the demethylation of aminopyrine in rats in vivo.
    Beckurts KT; Lauterburg BH
    Eur Surg Res; 1995; 27(2):111-6. PubMed ID: 7781642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclosporine and inflammatory bowel disease: buying time.
    Meijssen MA
    Mediators Inflamm; 1998; 7(3):145-7. PubMed ID: 9705599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accumulation of lovastatin, but not pravastatin, in the blood of cyclosporine-treated kidney graft patients after multiple doses.
    Olbricht C; Wanner C; Eisenhauer T; Kliem V; Doll R; Boddaert M; O'Grady P; Krekler M; Mangold B; Christians U
    Clin Pharmacol Ther; 1997 Sep; 62(3):311-21. PubMed ID: 9333107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atorvastatin does not affect the pharmacokinetics of cyclosporine in renal transplant recipients.
    Hermann M; Asberg A; Christensen H; Reubsaet JL; Holdaas H; Hartmann A
    Eur J Clin Pharmacol; 2005 Mar; 61(1):59-62. PubMed ID: 15711834
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Self-reported compliance with topical cyclosporine emulsion 0.05% and onset of the effects of increased tear production as assessed through patient surveys.
    Trattler W; Katsev D; Kerney D
    Clin Ther; 2006 Nov; 28(11):1848-56. PubMed ID: 17213005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of cyclosporine on human dendritic cell subsets.
    Ciesek S; Ringe BP; Strassburg CP; Klempnauer J; Manns MP; Wedemeyer H; Becker T
    Transplant Proc; 2005; 37(1):20-4. PubMed ID: 15808533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rifampin and ansamycin interactions with cyclosporine after renal transplantation.
    Vandevelde C; Chang A; Andrews D; Riggs W; Jewesson P
    Pharmacotherapy; 1991; 11(1):88-9. PubMed ID: 2020617
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Cyclosporine and psoriasis: experience with 14 patients].
    Gajardo J
    Rev Med Chil; 1993 Dec; 121(12):1411-5. PubMed ID: 8085065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.